Activation of cPLA2 in vascular smooth muscle.
LaBelle
E F
EF
Department of Physiology, Allegheny University of the Health Sciences, Philadelphia, PA 19129, USA.
Polyak
E
E
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D001095:Arachidonic Acids / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects / Q000201:enzymology; D003512:Cyclohexanones / Q000494:pharmacology; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004963:Estrenes / Q000494:pharmacology; D066298:In Vitro Techniques; D007527:Isoenzymes / Q000378:metabolism*; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology*; D009281:Naphthalenes / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010741:Phospholipases A / Q000378:metabolism*; D011753:Pyrones / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats; D013729:Terpenes / Q000494:pharmacology; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000378:metabolism
D001095:Arachidonic Acids; D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D004963:Estrenes; D007527:Isoenzymes; D009281:Naphthalenes; D011753:Pyrones; D011760:Pyrrolidinones; D013729:Terpenes; C081565:arachidonyltrifluoromethane; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; D016718:Arachidonic Acid; C036535:1,6-bis(cyclohexyloximinocarbonyl)hexane; C068314:6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one; C045673:manoalide; D010741:Phospholipases A; D008071:Lipoprotein Lipase; D010738:Type C Phospholipases; D009638:Norepinephrine